Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

por Ling, Xiang, Calinski, Diane, Chanan-Khan, Asher A, Zhou, Muxiang, Li, Fengzhi
Publicado 2010

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review

por Parrondo, Ricardo D., Roy, Vivek, Sher, Taimur, Alegria, Victoria, Chanan-Khan, Asher A., Ailawadhi, Sikander
Publicado 2020

Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications

por Paulus, Aneel, Chitta, Kasyapa S., Wallace, Paul K., Advani, Pooja P., Akhtar, Sharoon, Kuranz-Blake, Maja, Ailawadhi, Sikander, Chanan-Khan, Asher A.
Publicado 2015

Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells

por Rozanski, Cheryl H., Arens, Ramon, Carlson, Louise M., Nair, Jayakumar, Boise, Lawrence H., Chanan-Khan, Asher A., Schoenberger, Stephen P., Lee, Kelvin P.
Publicado 2011

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes

por Swaika, Abhisek, Frank, Ryan D., Yang, Dongyun, Finn, Laura E., Jiang, Liuyan, Advani, Pooja, Chanan‐Khan, Asher A., Ailawadhi, Sikander, Foran, James M.
Publicado 2017

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström Macroglobulinemia

por Gaudette, Brian T., Dwivedi, Bhakti, Chitta, Kasyapa S., Poulain, Stéphanie, Powell, Doris, Vertino, Paula, Leleu, Xavier, Lonial, Sagar, Chanan-Khan, Asher A., Kowalski, Jeanne, Boise, Lawrence H.
Publicado 2015

The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers

por Ailawadhi, Sikander, Ailawadhi, Meghna, Dutta, Navnita, Parrondo, Ricardo D., Roy, Vivek, Sher, Taimur, Baksh, Mizba, Rasheed, Ahsan, Das, Saurav, Fernandez, Andre J., Paulus, Aneel, Chanan‐Khan, Asher A.
Publicado 2023

Dihydronicotinamide Riboside Is a Potent NAD(+) Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages

por Chini, Claudia C. S., Peclat, Thais R., Gomez, Lilian S., Zeidler, Julianna D., Warner, Gina M., Kashyap, Sonu, Mazdeh, Delaram Z., Hayat, Faisal, Migaud, Marie E., Paulus, Aneel, Chanan-Khan, Asher A., Chini, Eduardo N.
Publicado 2022

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis

por Ailawadhi, Sikander, Frank, Ryan D., Advani, Pooja, Swaika, Abhisek, Temkit, M'hamed, Menghani, Richa, Sharma, Mayank, Meghji, Zahara, Paulus, Shumail, Khera, Nandita, Hashmi, Shahrukh K., Paulus, Aneel, Kakar, Tanya S., Hodge, David O., Colibaseanu, Dorin T., Vizzini, Michael R., Roy, Vivek, Colon‐Otero, Gerardo, Chanan‐Khan, Asher A.
Publicado 2017

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma

por Ailawadhi, Sikander, Parrondo, Ricardo D., Dutta, Navnita, Han, Bing, Ciccio, Gina, Cherukuri, Yesesri, Alegria, Victoria R., LaPlant, Betsy R., Roy, Vivek, Sher, Taimur, Edwards, Brett, Lanier, Stephanie, Manna, Alak, Heslop, Keisha, Caulfield, Thomas, Maldosevic, Emir, Storz, Peter, Manochakian, Rami, Asmann, Yan, Chanan-Khan, Asher A., Paulus, Aneel
Publicado 2023

The role of (18)F-FDG-PET in detecting Richter transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor

por Wang, Yucai, Rabe, Kari G., Bold, Michael S., Shi, Min, Hanson, Curtis A., Schwager, Susan M., Call, Timothy G., Kenderian, Saad S., Muchtar, Eli, Hayman, Suzanne R., Koehler, Amber B., Fonder, Amie L., Chanan-Khan, Asher A., Van Dyke, Daniel L., Slager, Susan L., Kay, Neil E., Ding, Wei, Leis, Jose F., Parikh, Sameer A.
Publicado 2020

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

por Stewart, A. Keith, Krishnan, Amrita Y., Singhal, Seema, Boccia, Ralph V., Patel, Manish R., Niesvizky, Ruben, Chanan-Khan, Asher A., Ailawadhi, Sikander, Brumm, Jochen, Mundt, Kirsten E., Hong, Kyu, McBride, Jacqueline, Shon-Nguyen, Quyen, Xiao, Yuanyuan, Ramakrishnan, Vanitha, Polson, Andrew G., Samineni, Divya, Leipold, Douglas, Humke, Eric W., McClellan, James Scott, Berdeja, Jesus G.
Publicado 2019

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

por Parikh, Sameer A., Achenbach, Sara J., Call, Timothy G., Rabe, Kari G., Ding, Wei, Leis, Jose F., Kenderian, Saad S., Chanan‐Khan, Asher A., Koehler, Amber B., Schwager, Susan M., Muchtar, Eli, Fonder, Amie L., McCullough, Kristen B., Nedved, Adrienne N., Smith, Matthew D., Slager, Susan L., Kay, Neil E., Finnes, Heidi D., Shanafelt, Tait D.
Publicado 2020

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib

por Hampel, Paul J., Rabe, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Chanan-Khan, Asher A., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber B., Parrondo, Ricardo, Schwager, Susan M., Sher, Taimur, Hanson, Curtis A., Shi, Min, Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.
Publicado 2022

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

por Weisel, Katja, Spencer, Andrew, Lentzsch, Suzanne, Avet-Loiseau, Hervé, Mark, Tomer M., Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay, Quach, Hang, Munder, Markus, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Chanan-Khan, Asher A., Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Casneuf, Tineke, DeAngelis, Nikki, Amin, Himal, Ukropec, Jon, Kobos, Rachel, Mateos, Maria-Victoria
Publicado 2020

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

por Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M., Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K., Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C., Chanan-Khan, Asher A., Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A. Kate, Schecter, Jordan M., Mateos, Maria-Victoria
Publicado 2018

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

por Gonsalves, Wilson I., Buadi, Francis K., Ailawadhi, Sikander, Bergsagel, P. Leif, Chanan Khan, Asher A., Dingli, David, Dispenzieri, Angela, Fonseca, Rafael, Hayman, Susan R., Kapoor, Prashant, Kourelis, Taxiarchis V., Lacy, Martha Q., Larsen, Jeremy T., Muchtar, Eli, Reeder, Craig B., Sher, Taimur, Stewart, A. Keith, Warsame, Rahma, Go, Ronald S., Kyle, Robert A., Leung, Nelson, Lin, Yi, Lust, John A., Russell, Stephen J., Zeldenrust, Stephen R., Fonder, Amie L., Hwa, Yi L., Hobbs, Miriam A., Mayo, Angela A., Hogan, William J., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A., Roy, Vivek
Publicado 2018

Molecular Modeling and Functional Analysis of Exome Sequencing–Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma

por Egan, Jan B., Marks, David L., Hogenson, Tara L., Vrabel, Anne M., Sigafoos, Ashley N., Tolosa, Ezequiel J., Carr, Ryan M., Safgren, Stephanie L., Enriquez Hesles, Elisa, Almada, Luciana L., Romecin-Duran, Paola A., Iguchi, Eriko, Ala’Aldeen, Aryan, Kocher, Jean-Pierre A., Oliver, Gavin R., Prodduturi, Naresh, Mead, David W., Hossain, Asif, Huneke, Norine E., Tagtow, Colleen M., Ailawadhi, Sikander, Ansell, Stephen M., Banck, Michaela S., Bryce, Alan H., Carballido, Estrella M., Chanan-Khan, Asher A., Curtis, Kelly K., Resnik, Ernesto, Gawryletz, Chelsea D., Go, Ronald S., Halfdanarson, Thorvardur R., Ho, Thai H., Joseph, Richard W., Kapoor, Prashant, Mansfield, Aaron S., Meurice, Nathalie, Nageswara Rao, Amulya A., Nowakowski, Grzegorz S., Pardanani, Animesh, Parikh, Sameer A., Cheville, John C., Feldman, Andrew L., Ramanathan, Ramesh K., Robinson, Steven I., Tibes, Raoul, Finnes, Heidi D., McCormick, Jennifer B., McWilliams, Robert R., Jatoi, Aminah, Patnaik, Mrinal M., Silva, Alvin C., Wieben, Eric D., McAllister, Tammy M., Rumilla, Kandelaria M., Kerr, Sarah E., Lazaridis, Konstantinos N., Farrugia, Gianrico, Stewart, A. Keith, Clark, Karl J., Kennedy, Eileen J., Klee, Eric W., Borad, Mitesh J., Fernandez-Zapico, Martin E.
Publicado 2017